Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Trastornos del Movimiento
FILTRAR POR:
Por tema
5195 ARTÍCULOS , VIENDO DEL 901 AL 915
Lysosomal Ceramide Metabolism Disorders: Implications in Parkinson's Disease
Paciotti S, Albi E, Parnetti L, Beccari T.
J Clin Med. 2020 Feb 21;9(2):594. doi: 10.3390/jcm9020594.
Uzuegbunam BC, Librizzi D, Hooshyar Yousefi B.
Molecules. 2020 Feb 21;25(4):977. doi: 10.3390/molecules25040977.
Physiotherapy for freezing of gait in Parkinson's disease: a systematic review and meta-analysis
Miller KJ, Suárez-Iglesias D, Seijo-Martínez M, Ayán C.
Rev Neurol. 2020 Mar 1;70(5):161-170. doi: 10.33588/rn.7005.2019417.
Transsynaptic tracing and its emerging use to assess graft-reconstructed neural circuits
Adler AF, Björklund A, Parmar M.
Stem Cells. 2020 Jun;38(6):716-726. doi: 10.1002/stem.3166. Epub 2020 Mar 5.
Cognitive training interventions for dementia and mild cognitive impairment in Parkinson's disease
Orgeta V, McDonald KR, Poliakoff E, Hindle JV, Clare L, Leroi I.
Cochrane Database Syst Rev. 2020 Feb 26;2(2):CD011961. doi: 10.1002/14651858.CD011961.pub2.
Subthalamic Gamma Knife Radiosurgery in Parkinson's Disease: A Cautionary Tale
Drummond PS, Pourfar MH, Hill TC, Mogilner AY, Kondziolka DS.
Stereotact Funct Neurosurg. 2020;98(2):110-117. doi: 10.1159/000505709. Epub 2020 Feb 26.
Considerations for trials of disease modifying treatments in Parkinson disease
Ahlskog JE.
Neurology. 2020 Mar 17;94(11):467-468. doi: 10.1212/WNL.0000000000009127. Epub 2020 Feb 26.
Disease modification and biomarker development in Parkinson disease: Revision or reconstruction?
Espay AJ, Kalia LV, Gan-Or Z, Williams-Gray CH, Bedard PL, Rowe SM, Morgante F, Fasano A, Stecher B, Kauffman MA, Farrer MJ, Coffey CS, Schwarzschild MA, Sherer T, Postuma RB, Strafella AP, Singleton AB, Barker RA, Kieburtz K, Olanow CW, Lozano A, Kordower JH, Cedarbaum JM, Brundin P, Standaert DG, Lang AE.
Neurology. 2020 Mar 17;94(11):481-494. doi: 10.1212/WNL.0000000000009107. Epub 2020 Feb 26.
Gut, oral and nasal microbiota and Parkinson's disease
Shen L.
Microb Cell Fact. 2020 Feb 27;19(1):50. doi: 10.1186/s12934-020-01313-4.
Dropped Head Syndrome: An Update on Etiology and Surgical Management
Brodell JD Jr, Sulovari A, Bernstein DN, Mongiovi PC, Ciafaloni E, Rubery PT, Mesfin A.
JBJS Rev. 2020 Jan;8(1):e0068. doi: 10.2106/JBJS.RVW.19.00068.
Glucocerebrosidase as a therapeutic target for Parkinson's disease
Chen Y, Sam R, Sharma P, Chen L, Do J, Sidransky E.
Expert Opin Ther Targets. 2020 Apr;24(4):287-294. doi: 10.1080/14728222.2020.1733970. Epub 2020 Feb 27.
Coating Materials for Neural Stem/Progenitor Cell Culture and Differentiation
Liu D, Pavathuparambil Abdul Manaph N, Al-Hawwas M, Bobrovskaya L, Xiong LL, Zhou XF.
Stem Cells Dev. 2020 Apr 15;29(8):463-474. doi: 10.1089/scd.2019.0288. Epub 2020 Mar 31.
Krauss R, Bosanac T, Devraj R, Engber T, Hughes RO.
Trends Pharmacol Sci. 2020 Apr;41(4):281-293. doi: 10.1016/j.tips.2020.01.006. Epub 2020 Feb 24.
Faustman DL.
J Intern Med. 2020 Dec;288(6):641-650. doi: 10.1111/joim.13050. Epub 2020 Mar 18.
Impact of gastrointestinal physiology on drug absorption in special populations--An UNGAP review
Stillhart C, Vučićević K, Augustijns P, Basit AW, Batchelor H, Flanagan TR, Gesquiere I, Greupink R, Keszthelyi D, Koskinen M, Madla CM, Matthys C, Miljuš G, Mooij MG, Parrott N, Ungell AL, de Wildt SN, Orlu M, Klein S, Müllertz A.
Eur J Pharm Sci. 2020 Apr 30;147:105280. doi: 10.1016/j.ejps.2020.105280. Epub 2020 Feb 25.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.